Vermeire P - Search Results

1

A phase II trial of dose-escalated doxorubicin and ifosfamide/mesna in patients with malignant mesothelioma.

Dirix LY, van Meerbeeck J, Schrijvers D, Corthouts B, Prové A, van Marck E, Vermeire P, van Oosterom AT. Dirix LY, et al. Among authors: vermeire p. Ann Oncol. 1994 Sep;5(7):653-5. doi: 10.1093/oxfordjournals.annonc.a058941. Ann Oncol. 1994. PMID: 7993844 Free article. Clinical Trial.

2

Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1.

Ramael M, van den Bossche J, Buysse C, van Meerbeeck J, Segers K, Vermeire P, van Marck E. Ramael M, et al. Among authors: vermeire p. J Pathol. 1992 May;167(1):5-8. doi: 10.1002/path.1711670103. J Pathol. 1992. PMID: 1352542

3

Disseminated lung cancer or extragonadal germ cell tumour?

Wouters E, Van Meerbeeck J, Dirix L, Janssen M, Van Marck E, Vermeire P, Van Oosterom A. Wouters E, et al. Among authors: vermeire p. Eur Respir J. 1991 Jan;4(1):84-7. Eur Respir J. 1991. PMID: 1851105

4

Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA).

Ramael M, Jacobs W, Weyler J, Van Meerbeeck J, Białasiewicz P, Van den Bossche J, Buysse C, Vermeire P, Van Marck E. Ramael M, et al. Among authors: vermeire p. J Pathol. 1994 Mar;172(3):247-53. doi: 10.1002/path.1711720304. J Pathol. 1994. PMID: 7910850

5

Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium.

Segers K, Ramael M, Singh SK, Weyler J, Van Meerbeeck J, Vermeire P, Van Marck E. Segers K, et al. Among authors: vermeire p. Virchows Arch. 1994;424(6):631-4. doi: 10.1007/BF00195777. Virchows Arch. 1994. PMID: 8055157

6

Evaluation and prognostic value of DNA content and of morphometric parameters in malignant mesothelioma using digital image analysis.

Segers K, Singh SK, Van Daele A, Bogers J, Van Meerbeeck J, Vermeire P, Weyler J, Van Marck E. Segers K, et al. Among authors: vermeire p. Lung Cancer. 1996 Jun;14(2-3):229-37. doi: 10.1016/0169-5002(95)00549-8. Lung Cancer. 1996. PMID: 8794406

7

Metastatic pleural effusion as presenting sign of prostatic carcinoma.

Druwé PM, Verresen DA, Van Meerbeeck JP, Van Marck EA, Vermeire PA. Druwé PM, et al. Among authors: vermeire pa. Acta Clin Belg. 1995;50(4):227-30. doi: 10.1080/17843286.1995.11718451. Acta Clin Belg. 1995. PMID: 7483974

8

Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship?

Verresen D, De Backer W, Van Meerbeeck J, Neetens I, Van Marck E, Vermeire P. Verresen D, et al. Among authors: vermeire p. Eur Respir J. 1991 May;4(5):629-31. Eur Respir J. 1991. PMID: 1936235

9

Endobronchial inflammatory pseudotumour in a patient with B-cell chronic lymphocytic leukemia and malignant pleural mesothelioma.

Stappaerts I, Van Schil PE, Van Marck E, Vermeire P. Stappaerts I, et al. Among authors: vermeire p. Acta Clin Belg. 1996;51(4):261-4. doi: 10.1080/22953337.1996.11718519. Acta Clin Belg. 1996. PMID: 8858892 Review.

10

Atypical bronchial carcinoid tumours.

Struyf NJ, Van Meerbeeck JP, Ramael MR, Van Schil PE, Van Marck EA, Vermeire PA. Struyf NJ, et al. Among authors: vermeire pa. Respir Med. 1995 Feb;89(2):133-8. doi: 10.1016/0954-6111(95)90196-5. Respir Med. 1995. PMID: 7708998 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters